Anika Therapeutics (ANIK) Change in Inventory (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Change in Inventory data on file, last reported at $5.4 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $5.4 million, up 1133.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.9 million (up 22.64% YoY), and the FY2025 annual result was -$30000.0, down 100.32% from the prior year.
• Change in Inventory climbed to $5.4 million in Q1 2026 per ANIK's latest filing, from $1.8 million in the prior quarter.
• Over five years, Change in Inventory peaked at $5.4 million in Q1 2026 and troughed at -$2.4 million in Q4 2024.
• A 5-year average of $1.9 million and a median of $2.4 million in 2022 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2024 and 2026: Change in Inventory plunged 176.17% in 2024, then jumped 1133.84% in 2026.
• A 5-year view of Change in Inventory shows it stood at $2.9 million in 2022, then climbed by 6.77% to $3.1 million in 2023, then sank by 176.17% to -$2.4 million in 2024, then surged by 174.4% to $1.8 million in 2025, then jumped by 203.93% to $5.4 million in 2026.
• Business Quant data shows ANIK's Change in Inventory at $5.4 million in Q1 2026, $1.8 million in Q4 2025, and $443000.0 in Q3 2025.